Relapsed Diffuse large B-cell lymphoma NOS
Drug | Drug Name | Drug Description |
---|---|---|
DB16222 | Loncastuximab tesirine | An antibody-drug conjugate used for the treatment of relapsed and refractory B-cell lymphomas. |
DB12240 | Polatuzumab vedotin | A CD79b antibody conjugate indicated to treat different types of large B-cell lymphoma. |
DB11942 | Selinexor | Selinexor is indicated in combination with bortezomib and dexamethasone for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. Selinexor is also indicated... |
DB15044 | Tafasitamab | A CD19-directed cytolytic monoclonal antibody used in the treatment of B-cell malignancies. |
Drug | Drug Name | Phase | Status | Count |
---|